Histological subtypes of solitary pulmonary nodules of adenocarcinoma and their clinical relevance

Journal of Thoracic Disease

Volumn 5, Issue 6, 2013, Pages 841-846

  Hu, Hui Di ^a   Wan, Ming Yue ^a   Xu, Chun Hua ^a,b   Zhan, Ping ^a,b   Zou, Jue ^a   Zhang, Qian Qian ^a   Zhang, Yuan Qing ^a  

^a NANJING CHEST HOSPITAL   (China)

^b Center for Diseases Control of Nanjing   (China)

Author keywords

Adenocarcinoma solitary pulmonary nodule (SPNs); Clinical manifestations; Histological subtype

Indexed keywords

MUCIN;

ACINAR PREDOMINANT ADENOCARCINOMA; ADENOCARCINOMA; ADULT; AGED; ARTICLE; CANCER CLASSIFICATION; CONTROLLED STUDY; FEMALE; HISTOPATHOLOGY; HUMAN; HUMAN TISSUE; LEPIDIC PREDOMINANT ADENOCARCINOMA; LUNG ADENOCARCINOMA; LUNG NODULE; LYMPH NODE METASTASIS; MAJOR CLINICAL STUDY; MALE; MICROPAPILLARY PREDOMINANT ADENOCARCINOMA; PAPILLARY PREDOMINANT ADENOCARCINOMA; PROGNOSIS; RETROSPECTIVE STUDY; SEX DIFFERENCE; SOLID PREDOMINANT ADENOCARCINOMA;

EID: 84892392241     PISSN: 20721439     EISSN: 20776624     Source Type: Journal    
DOI: 10.3978/j.issn.2072-1439.2013.12.16     Document Type: Article

References (30)

1. Ost D, Fein AM, Feinsilver SH. Clinical practice. The solitary pulmonary nodule. N Engl J Med 2003;348:2535-42.
2. Dargan EL. The enigma of the solitary pulmonary nodule. J Natl Med Assoc 1973;65:101-3 passim.
3. Gould MK, Ghaus SJ, Olsson JK, et al. Timeliness of care in veterans with non-small cell lung cancer. Chest 2008;133:1167-73.
4. Tmvis WD, Brambills E, Noguchi M, et al. International association for the study of lung cancer/American thoracic society/European respiratory society international muhidisciplinary classification of lung adenocarcinoma. J Thoracic Oncol 2011;6:244-85.
5. Yoshizawa A, Motoi N, Riely GJ, et al. Impact of proposed IASLC/ATS/ERS classification of lung adenocarcinoma: prognostic subgroups and implications for further revision of staging based on analysis of 514 stage I cases. Mod Pathol 2011;24:653-64.
6. Ding FG, Liu B, Zhang XH, et al. Prognostic significance of a newly proposed grading and scoring system in stage I pulmonary adenocarcinoma. Zhonghua Bing Li Xue Za Zhi 2012;41:145-50.
7. Xu L, Tavora F, Burke A. Histologic features associated with metastatic potential in invasive adenocarcinomas of the lung. Am J Surg Pathol 2013;37:1100-8.
8. Hung JJ, Jeng WJ, Chou TY, et al. Prognostic value of the new International Association for the Study of Lung Cancer/American Thoracic Society/European Respiratory Society lung adenocarcinoma classification on death and recurrence in completely resected stage I lung adenocarcinoma. Ann Surg 2013;258:1079-86.
9. Kadota K, Colovos C, Suzuki K, et al. FDG-PET SUVmax combined with IASLC/ATS/ERS histologic classification improves the prognostic stratification of patients with stage I lung adenocarcinoma. Ann Surg Oncol 2012;19:3598-605.
10. Song Z, Zhu H, Guo Z, et al. Prognostic value of the IASLC/ATS/ERS classification in stage I lung adenocarcinoma patients--based on a hospital study in China. Eur J Surg Oncol 2013;39:1262-8.
11. Warth A, Muley T, Meister M, et al. The novel histologic International Association for the Study of Lung Cancer/American Thoracic Society/European Respiratory Society classification system of lung adenocarcinoma is a stage-independent predictor of survival. J Clin Oncol 2012;30:1438-46.
12. Russell PA, Wainer Z, Wright GM, et al. Does lung adenocarcinoma subtype predict patient survival?: a clinicopathologic study based on the new International Association for the Study of Lung Cancer/American Thoracic Society/European Respiratory Society international multidisciplinary lung adenocarcinoma classification. J Thorac Oncol 2011;6:1496-504.
13. Woo T, Okudela K, Mitsui H, et al. Prognostic value of the IASLC/ATS/ERS classification of lung adenocarcinoma in stage I disease of Japanese cases. Pathol Int 2012;62:785-91.
14. Yoshizawa A, Sumiyoshi S, Sonobe M, et al. Validation of the IASLC/ATS/ERS lung adenocarcinoma classification for prognosis and association with EGFR and KRAS gene mutations: analysis of 440 Japanese patients. J Thorac Oncol 2013;8:52-61.
15. Russell PA, Barnett SA, Walkiewicz M, et al. Correlation of mutation status and survival with predominant histologic subtype according to the new IASLC/ATS/ERS lung adenocarcinoma classification in stage III (N2) patients. J Thorac Oncol 2013;8:461-8.
16. Yanagawa N, Shiono S, Abiko M, et al. New IASLC/ATS/ERS classification and invasive tumor size are predictive of disease recurrence in stage I lung adenocarcinoma. J Thorac Oncol 2013;8:612-8.
17. Zhang J, Wu J, Tan Q, et al. Why do pathological stage IA lung adenocarcinomas vary from prognosis?: a clinicopathologic study of 176 patients with pathological stage IA lung adenocarcinoma based on the IASLC/ATS/ERS classification. J Thorac Oncol 2013;8:1196-202.
18. Gu J, Lu C, Guo J, et al. Prognostic significance of the IASLC/ATS/ERS classification in Chinese patients-A single institution retrospective study of 292 lung adenocarcinoma. J Surg Oncol 2013;107:474-80.
19. Tsuta K, Kawago M, Inoue E, et al. The utility of the proposed IASLC/ATS/ERS lung adenocarcinoma subtypes for disease prognosis and correlation of driver gene alterations. Lung Cancer 2013;81:371-6.
20. Kadota K, Yeh YC, Sima CS, et al. The cribriform pattern identifies a subset of acinar predominant tumors with poor prognosis in patients with stage I lung adenocarcinoma: a conceptual proposal to classify cribriform predominant tumors as a distinct histologic subtype. Mod Pathol 2013. [Epub ahead of print].
21. von der Thüsen JH, Tham YS, Pattenden H, et al. Prognostic significance of predominant histologic pattern and nuclear grade in resected adenocarcinoma of the lung: potential parameters for a grading system. J Thorac Oncol 2013;8:37-44.
22. Comstock GW, Vaughan RH, Montgomery G. Outcome of solitary pulmonary nodules discovered in an x-ray screening program. N Engl J Med 1956;254:1018-22.
23. Xu Y, Zhou XJ, Dong YC, et al. Prognostic significance and grading of stromal invasion in pT1 adenocarcinoma of lung. Zhonghua Bing Li Xue Za Zhi 2009;38:451-5.
24. Amin MB, McKenney JK. An approach to the diagnosis of flat intraepithelial lesions of the urinary bladder using the World Health Organization/International Society of Urological Pathology consensus classification system. Adv Anat Pathol 2002;9:222-32.
25. Yim J, Zhu LC, Chiriboga L, et al. Histologic features are important prognostic indicators in early stages lung adenocarcinomas. Mod Pathol 2007;20:233-41.
26. Borczuk AC, Qian F, Kazeros A, et al. Invasive size is an independent predictor of survival in pulmonary adenocarcinoma. Am J Surg Pathol 2009;33:462-9.
27. Sakurai H, Maeshima A, Watanabe S, et al. Grade of stromal invasion in small adenocarcinoma of the lung: histopathological minimal invasion and prognosis. Am J Surg Pathol 2004;28:198-206.
28. Barletta JA, Yeap BY, Chirieac LR. Prognostic significance of grading in lung adenocarcinoma. Cancer 2010;116:659-69.
29. Sakurai H, Maeshima A, Watanabe S, et al. Grade of stromal invasion in small adenocarcinoma of the lung: histopathological minimal invasion and prognosis. Am J Surg Pathol 2004;28:198-206.
30. Martini N, Bains MS, Burt ME, et al. Incidence of local recurrence and second primary tumors in resected stage I lung cancer. J Thorac Cardiovasc Surg 1995;109:120-9.